Mesa Laboratories operates through four primary business segments: Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. The company's product portfolio includes biological and chemical indicators, automated systems for protein analysis, peptide synthesis solutions, and advanced metrology tools for environmental and process monitoring. Mesa Labs maintains manufacturing facilities in North America and Europe, generating approximately half of its revenues from international markets. The company's competitive position is supported by a high proportion of recurring revenue derived from consumables and ongoing calibration services. By focusing on mission-critical quality control processes, Mesa Labs benefits from the stringent regulatory compliance requirements mandated across the life sciences and healthcare sectors. The company has historically expanded its market presence and technological capabilities through a combination of organic development and strategic acquisitions.
